Ticagrelor, but Not Clopidogrel, Attenuates Hepatic Steatosis in a Model of Metabolic Dysfunction-Associated Steatotic Liver Disease

Ticagrelor, but Not Clopidogrel, Attenuates Hepatic Steatosis in a Model of Metabolic Dysfunction-Associated Steatotic Liver Disease

Background: Previous studies have suggested that platelets are associated with inflammation and steatosis and may play an important role in liver health. Therefore, we evaluated whether antiplatelet agents can improve metabolic disorder-related fatty liver disease (MASLD). Methods: The mice used in...

Full description

Bibliographic Details
Main Authors: Eun Jeoung Lee, Seung Min Lee, Ju Hee Oh, Hye Young Kim, Waqar Khalid Saeed, Hyun Sung Kim, Dae Won Jun
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Nutrients
Subjects:
non-alcoholic fatty liver disease
liver biopsy
clopidogrel
ticagrelor
lipogenesis
Online Access:https://www.mdpi.com/2072-6643/16/7/920

Internet

https://www.mdpi.com/2072-6643/16/7/920

Similar Items